Eterna Therapeutics 株価情報 (NASDAQ: ERNA)

最新ニュース Eterna Therapeutics (NASDAQ:ERNA) 株価情報

Eterna Therapeutics

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

Eterna Therapeutics Inc

&#8220;When do you keep a stock? When do you sell it, and when do you add to it?&#8221; That's the question <a href="https://www.benzinga.com/personal-finance/25/02/43737751/suze-orman-weighs-in-on-trumps-tariffs-says-the-real-problem-is-28000-florida-home-insurance-what-are-you-going-to-do-about-that">Suze Orman</a> recently posed on her "Women &amp; Money" podcast — and it's one that many investors struggle with, especially during market volatility. Investing in the stock market can be intimidating, and when prices start to drop, it's easy to panic and make emotional decisions. But Orman advises that reacting out of fear is often a mistake.&nbsp;
<h2 class="wp-block-heading">Why Fear Can Be Dangerous for Investors</h2>
&#8220;The main internal obstacle to wealth is fear,&#8221; Orman said. &#8220;Fear, everybody, just that simple.&#8221; She pointed out that fear is pervasive right now, driven by economic uncertainty, rising costs, and geopolitical tensions.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a></li>
</ul>
This fear can lead to knee-jerk reactions in the stock market. Orman explained that when investors panic and sell off stock, it can drive prices down further. Orman used Palantir as an example. In the last month, it has dropped from about $125 a share to below $80 a share.&nbsp;&nbsp;
&#8220;You feel good for a while, cause maybe you sold <a href="https://www.benzinga.com/markets/equities/25/03/44212796/palantir-joins-sp-100-after-ai-driven-rally-stock-surges-almost-60-since-trump-victory">Palantir</a> at 95, and now here it&#8217;s at 85 and you feel like such a winner. Are you kidding me?&#8221; she said, adding that short-term gains from selling out of fear can result in missed long-term growth opportunities.
Trending: The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a>
<h2 class="wp-block-heading">When to Keep a Stock</h2>
Orman advises that if a stock has strong fundamentals — good management, a solid product, and future growth potential — you should hold onto it even if the market dips. She reminded listeners about the market downturn in 2022 when major tech stocks like Apple, Microsoft, and Nvidia performed poorly. &#8220;They were referred to as the Stinky 7 because of how badly they had gone down,&#8221; Orman said.
But those who stayed invested saw significant returns. Nvidia, for example, rebounded with a 240% gain in 2023. Orman reminded listeners that those who bought stock at much lower prices were still sitting on significant gains. And even if they didn't, if the stock is fundamentally strong, it&#8217;s better to stay invested rather than react impulsively to market swings.
Trending: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
<h2 class="wp-block-heading">When to Sell a Stock</h2>
While holding onto <a href="https://www.benzinga.com/money/best-stocks-for-long-term-investment">strong stocks</a> can lead to long-term gains, there are times when selling makes sense. Orman advised selling if a stock's value becomes too large a portion of your overall portfolio. This helps to reduce the risk of losing too much if the stock suddenly drops.
She explained that selling can also be a smart move if you need the funds for other investments or financial goals. However, Orman warned against selling just because the stock has gone up or down temporarily. Taking profits too soon can lead to missed opportunities if the stock rebounds.
<h2 class="wp-block-heading">When to Add to a Stock</h2>
Orman supports adding to a stock position when you have the funds to do so strategically — through <a href="https://www.benzinga.com/personal-finance/25/02/43759719/suze-school-lump-sum-investing-dollar-cost-averaging-and-value-cost-average-which-is-her-favorite">dollar-cost averaging</a>. This means investing smaller amounts consistently over time, which reduces the risk of buying at a peak. &#8220;You have another $300 that you can put into Palantir totally. So all right, put $50 at a time in it so that you have at least six more times that you can buy the stock if it continues to go down,&#8221; she advised.
See Also: BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a>
Orman shared her own strategy with Palantir. She mentioned how she bought more shares when the price dropped from $113 to $98 and again when it hit $85. She said this approach lowers the average cost per share over time and allows for greater potential gains when the stock eventually rises. However, she also cautioned that this strategy works best for those who have the funds to continue buying as the price drops.
<h2 class="wp-block-heading">Bottom Line</h2>
Orman's advice boils down to staying calm and focused on long-term growth rather than reacting to market fear. Keeping, selling, or adding to a stock should be based on the strength of the company and your overall financial strategy — not panic over market swings.
Read Next:
<ul>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
</ul>

Personal Finance

'When Do You Keep A Stock? When Do You Sell It, And When Do You Add To It?' Suze Orman Says Don't Sell Out Of Fear

NAOV

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

APDN

Essential Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPRT#NYSE">EPRT</a>) has outperformed the market over the past 5 years by 7.82% on an annualized basis producing an average annual return of 24.7%. Currently, Essential Properties has a market capitalization of $5.73 billion. 
Buying $100 In EPRT: If an investor had bought $100 of EPRT stock 5 years ago, it would be worth $280.94 today based on a price of $30.51 for EPRT at the time of writing.
<h3>Essential Properties's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741909508_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

EPRT

$100 Invested In Essential Properties 5 Years Ago Would Be Worth This Much Today

Wells Fargo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) has outperformed the market over the past 5 years by 1.35% on an annualized basis producing an average annual return of 18.23%. Currently, Wells Fargo has a market capitalization of $226.88 billion. 
Buying $1000 In WFC: If an investor had bought $1000 of WFC stock 5 years ago, it would be worth $2,583.40 today based on a price of $69.00 for WFC at the time of writing.
<h3>Wells Fargo's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741908608_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Wells Fargo 5 Years Ago Would Be Worth This Much Today

Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) has outperformed the market over the past 5 years by 7.29% on an annualized basis producing an average annual return of 24.17%. Currently, Exxon Mobil has a market capitalization of $471.53 billion. 
Buying $1000 In XOM: If an investor had bought $1000 of XOM stock 5 years ago, it would be worth $3,150.77 today based on a price of $108.67 for XOM at the time of writing.
<h3>Exxon Mobil's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741907708_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Exxon Mobil Stock In The Last 5 Years

Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) reported quarterly earnings of $1.68 per share which beat the analyst consensus estimate of $1.50 by 12 percent. The company reported quarterly sales of $10.304 billion which beat the analyst consensus estimate of $10.264 billion by 0.39 percent. This is a 4.52 percent increase over sales of $9.859 billion the same period last year.

Earnings

Earnings Beats

Dollar Gen Q4 2024 Adj. EPS $1.68 Beats $1.50 Estimate, Sales $10.304B Beat $10.264B Estimate

Billionaire Elon Musk has become a central figure in President Donald Trump's White House administration playing a role in the Department of Government Efficiency, a move that could impact the Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44235956/tesla-bloodbath-to-continue-hedge-funder-says-musk-circus-could-lead-to-stock-dropping-95">stock price.</a>
A new poll of voters finds minimal approval of the billionaire's role.
What Happened: Musk recently said it was hard <a href="https://www.benzinga.com/markets/25/03/44242181/elon-musk-admits-juggling-between-tesla-doge-is-difficult-says-running-businesses-with-great-difficulty-a">juggling his responsibilities </a>between his companies, including Tesla and SpaceX, along with his government work.
A new CNN/SSRS <a href="https://www.cnn.com/2025/03/12/politics/cnn-poll-trump-economy/index.html">poll </a>found that Musk's work within the government may not be going over as well as the billionaire believes.
Musk scores an approval rating of 35% with a disapproval rating of 53% in the new poll shared Wednesday. Eleven percent of voters have no opinion on the billionaire in the poll.
For comparison, Trump scored an overall approval rating of 45% with a disapproval rating of 54%, similar to Musk. Trump's approval rating was down from 48% in a February CNN poll.
Vice President J.D. Vance has a favorable rating of 33% in the poll with an unfavorable rating of 44%. A higher number of voters had no opinion on Vance with 23% choosing this option.
In the new poll, 62% of voters said Musk does not have the "right experience" to make changes to the government while 61% said Musk does not have the "right judgment' to make changes.
Even some of Trump's supporters question the moves Musk is making with 28% of voters who see Trump's changes to the government necessary doubt Musk's judgment to make changes.
Sixty-two percent of voters in the poll say cuts being made by Trump and Musk are going too far.
Likely not a surprise, the poll results are split by political party with 90% of Republicans concerned about losing important federal programs. Seventy-three percent of Republicans say they are more concerned with fraud and waste than losing federal programs. Sixty-nine percent of Independents say they are more concerned about losing important federal programs.
The poll was conducted March 6 through March 9 and included the results from 1,206 adults. By political party, the poll was made up of 29% Democrats, 30% Republicans and 41% Independents.
Read Also: <a href="https://www.benzinga.com/25/03/44313499/elon-musk-is-a-gift-from-the-gods-why-a-venture-capitalist-thinks-billionaire-will-help-america-look-really-cool">Elon Musk Is &#8216;A Gift From The Gods&#8217;: Why A Venture Capitalist Thinks Tesla CEO Will Help America Look &#8216;Really Cool&#8217;</a>
Why It's Important: Polls on <a href="https://www.benzinga.com/politics/25/02/43880789/elon-musk-approval-rating-hits-41-voters-not-impressed-with-doge-work-and-calls-to-eliminate-departments">approval ratings for Musk</a> have become more frequent with his push into politics.
A February Emerson College poll of voters asked for approval ratings about how well Musk was doing at the Department of Government Efficiency. In that poll, Musk had a 41% approval rating, with 45% disapproving and 14% neutral.
In that poll, Musk had a lower approval rating than Trump at 48% and a higher disapproval rating at 42%.
That poll showed voters had minimal support for DOGE and the Trump administration's plans to eliminate the U.S. Agency for International Development (USAID) and the Department of Education.
The big question from the approval polls on Musk will be how they translate to the companies he runs.
Tesla&nbsp;took a hit to its brand value in a <a href="https://www.benzinga.com/news/global/25/01/43172806/tesla-lost-15-billion-in-brand-value-in-2024-report-says-did-elon-musks-political-push-hurt-ev-giant">Brand Finance survey </a>in 2024. The company lost $15 billion in brand value and dropped 18 places in the rankings to 36.
The electric vehicle company has been the subject of&nbsp;<a href="https://www.benzinga.com/news/global/25/01/43251316/tesla-faces-boycott-call-in-poland-over-musks-wwii-comments" target="_blank" rel="noreferrer noopener">calls for boycotts&nbsp;</a>in European nations due to Musk&#8217;s political beliefs. Sales of Tesla vehicles have <a href="https://www.benzinga.com/news/global/25/03/44128646/tesla-sales-drop-in-europe-in-february-some-countries-down-over-40-is-musks-political-push-hurting-ev-company">fallen in Europe.</a> 
Musk&#8217;s approval rating as a CEO and as a politician are likely two different things, but for investors and Tesla shareholders, the hope is that they can stay separate and not translate to overall disapproval of Musk as a person and leader.
TSLA Price Action: Tesla stock closed Thursday down 2.99% to $240.68 versus a 52-week trading range of $138.80 to $488.54. Tesla stock is down 36.5% year-to-date in 2025
Tesla stock is now trading below where it was when Trump won the 2024 election. Tesla stock closed at $251.44 on Nov. 5 and opened for trading at $284.67 on Nov. 6 after&nbsp;<a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election" target="_blank" rel="noreferrer noopener">Trump&#8217;s victory was confirmed</a>.
The stock is down over 50% from all-time highs set in December.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44176616/trump-vs-musk-tesla-to-be-hurt-by-tariffs-on-mexico-despite-friendship">Trump Vs. Musk: Tesla To Be Hurt By Tariffs On Mexico Despite Friendship</a></li>
</ul>
Photo: Joshua Sukoff via Shutterstock

Government

Politics

TSLA

Elon Musk Disapproval Rating 53% In New Poll: 62% Say Tesla CEO Doesn't Have 'Right Experience' To Make Changes To Government

Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) has outperformed the market over the past 5 years by 1.39% on an annualized basis producing an average annual return of 18.27%. Currently, Coherent has a market capitalization of $9.53 billion. 
Buying $1000 In COHR: If an investor had bought $1000 of COHR stock 5 years ago, it would be worth $2,765.96 today based on a price of $61.49 for COHR at the time of writing.
<h3>Coherent's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741906815_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COHR

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Shaquille O'Neal didn't build a <a href="https://www.benzinga.com/personal-finance/25/01/42818956/nba-legend-shaq-says-he-wont-care-if-he-loses-every-dime-of-his-500-million-net-worth-i-dont-even-work-for-money-i-work-for-fun">$500 million fortune</a> by handing out free money, and he's making sure his kids don't expect one, either. The four-time NBA champion turned business mogul believes in "respectable nepotism"—a system where <a href="https://www.benzinga.com/news/25/03/44220332/shaq-warns-that-giving-kids-everything-from-the-start-can-backfire-they-aint-in-a-good-place">his children don't get a dime</a> unless they prove they deserve it.
No trust fund freebies. No blank checks. Just business proposals, due diligence, and a solid plan—because in Shaq's world, you don't just ask for money; you earn it.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
</ul>
"If you want money, you better have a business plan," Shaq told <a href="https://www.businessinsider.com/shaq-kids-respectable-nepotism-nepo-baby-money-2023-8">Business Insider in 2023</a>. "You want me to be the bank? I'm gonna do exactly what the bank does."
According to the man who famously tells his kids, "We ain't rich, I'm rich," getting money from him isn't as simple as asking. If they want funding, they need to come with a pitch, revenue projections, and a solid plan—because "Dad" isn't handing over his hard-earned cash.&nbsp;
<h2 class="wp-block-heading">Shaq's Kids Are Learning the Hard Way</h2>
As of March, Shaq's six kids range from 18 to 28 years old, and while some have already put in the work, others are still figuring it out.
At 27, Myles wanted to be a DJ. Instead of just handing him money, Shaq made him present a business plan, just like he would with any investment. Once Myles proved he was serious, Shaq helped him get the necessary equipment—but from there, Myles built his own career. Now, he's headlining shows across the U.S., touring, and even held a residency at Wynn Las Vegas.
Trending: Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a>
Shaq's eldest daughter, Taahirah, 28, skipped the entertainment industry and built a corporate career, while Shareef, 25, pursued basketball, playing for UCLA, LSU, and now the NBA G League.
Then there's Amirah, 23, and Me'arah,18—still in school and yet to pitch a big idea, but Shaq has a different plan for them. He explains he wants his daughter to attend law school.&nbsp;
He's always emphasized education, telling Logan Paul in a 2022 podcast that his motto for his kids is, "<a href="https://www.benzinga.com/personal-finance/24/11/41869301/shaqs-got-a-500-million-fortune-but-his-kids-arent-getting-a-dime-without-earning-it-you-need-3-degrees-to-touch-daddys-cheese">In order to touch daddy's cheese, you gotta have three degrees</a>."
See Also: Become a futures trading pro, without spending any money – <a href="https://www.benzinga.com/money/plus-500-adv">why Plus500 is the top choice for beginner investors</a>
<h2 class="wp-block-heading">A Lesson from Jeff Bezos</h2>
Shaq didn't always think this way. His investment mindset changed after listening to Jeff Bezos, who once said that he only invests in <a href="https://www.benzinga.com/personal-finance/25/03/44068159/nba-legend-shaq-says-his-net-worth-quadrupled-once-he-took-note-from-jeff-bezos-and-started-investing-in-things-that-change-peoples-lives">businesses that will change people's lives</a>. Shaq took that advice and ran with it—shifting from short-term deals to long-term, high-impact investments.
"I heard Jeff Bezos say one time [that] he makes his investments based on if it's going to change people's lives," Shaq told <a href="https://www.wsj.com/video/shaquille-oneal-discusses-investing-franchising-and-donuts/8063A172-ABFF-496B-8700-4D51A6234054">The Wall Street Journal</a> in 2019. That shift quadrupled his net worth, and now, he's applying the same thinking to his kids—if they want an investment, they need to show impact.
<h2 class="wp-block-heading">No Free Rides in the O'Neal Household</h2>
Unlike many celebrity kids who inherit millions without lifting a finger, Shaq's children are learning real-world economics the hard way.
They're free to pursue DJing, corporate careers, basketball, or even law school—but they're not getting a check just for showing up.
And if they think they can just ask for money and skip the business plan?
They better get used to hearing "Next!"
Read Next:
<ul>
<li>The secret weapon in billionaire investor portfolios that you almost certainly don't own yet. <a href="https://www.benzinga.com/money/masterworks">See which asset class has outpaced the S&amp;P 500 (1995-2024) – and with near-zero correlation.</a></li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a></li>
</ul>

Shaq Makes His 6 Kids Pitch A Business Plan If They Want Cash — 'You Want Me To Be The Bank, I'm Gonna Do Exactly What The Bank Is Going To Do'

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Evergy, Cadence Bank, and Tyson Foods have rewarded shareholders for years and recently announced dividend increases. These companies currently offer dividend yields of around 3% to 4%.
Evergy
Evergy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVRG#NASDAQ">EVRG</a>) engages in the generation, transmission, distribution, and sale of electricity in the U.S. It generates electricity through coal, landfill gas, uranium, and natural gas and oil sources, as well as solar, wind, and other renewable sources.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a></li>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
</ul>
Evergy has increased its dividends every year for the last seven years. In its most recent dividend hike announcement on Nov. 7, the company raised the quarterly payout by 4% to $0.6675 per share, which is equal to an annual figure of $2.67 per share. The current dividend yield on the stock is 4.10%.
Evergy&#8217;s annual revenue as of Dec. 31 stood at $5.85 billion. As per its Q4 2024 report on Feb. 27, it posted revenues of $1.26 billion, above the consensus estimate of $1.24 billion, while EPS of $0.35 missed the consensus of $0.37.
Trending: Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a>
Cadence Bank
Cadence Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CADE#NYSE">CADE</a>) provides commercial banking and financial services in the U.S.&nbsp;
Cadence Bank has raised its dividends consecutively for the last 12 years. As per its most recent dividend hike announcement on Jan. 22, the company raised the quarterly payout by 10% to $0.275 per share, which is equal to an annual figure of $1.10 per share. The dividend yield on the stock is 3.78%.
Cadence Bank's annual revenue as of Sept. 30 stood at $1.37 billion. According to its Q4 2024 earnings release on Jan. 22, the company posted revenues of $450.70 million, below the consensus estimate of $457.6 million, while EPS of $0.70 came in above the consensus of $0.68.
Check out this <a href="https://www.benzinga.com/insights/short-sellers/25/03/44199958/looking-into-cadence-banks-recent-short-interest">article by Benzinga</a>, which looks into Cadence Bank&#8217;s recent short interest.
See Also: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Tyson Foods
Tyson Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) operates as a food company worldwide. It operates through four segments: Beef, Pork, Chicken, and Prepared Foods.
Tyson Foods has increased its dividends every year for the last 12 years. In its most recent dividend hike announcement on Aug. 8, the company's board raised the quarterly payout from $0.49 to $0.50 per share, equal to an annual figure of $2 per share. Currently, the dividend yield on the stock stands at 3.23%.
Tyson Foods' annual revenue as of Dec. 31 stood at $53.61 billion. In its most recent earnings release on Feb. 3, the company posted Q1 2025 revenues of $13.62 billion and EPS of $1.14. Both figures came in above the Street estimates.
Check out this <a href="https://www.benzinga.com/insights/short-sellers/25/03/44145657/how-do-investors-really-feel-about-tyson-foods">article by Benzinga</a> to learn how investors feel about Tyson Foods.
Evergy, Cadence Bank, and Tyson Foods are good choices for investors seeking reliable passive income. Their dividend yields of around 3% to 4% and long history of consistent hikes make them attractive to income-focused investors.
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
</ul>

CADE

EVRG

How Evergy, Cadence Bank, And Tyson Foods Can Put Cash In Your Pocket

UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) has outperformed the market over the past 10 years by 4.8% on an annualized basis producing an average annual return of 14.91%. Currently, UnitedHealth Group has a market capitalization of $440.45 billion. 
Buying $1000 In UNH: If an investor had bought $1000 of UNH stock 10 years ago, it would be worth $4,094.56 today based on a price of $481.52 for UNH at the time of writing.
<h3>UnitedHealth Group's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741905016_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In UnitedHealth Group 10 Years Ago Would Be Worth This Much Today

Venture capitalist Tim Draper has invested in companies such as Hotmail, Skype, Tesla and SpaceX over the years. While he's never invested in Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), he couldn't help but praise founder Jeff Bezos for <a href="https://www.benzinga.com/news/21/04/20675447/5-things-you-might-not-know-about-jeff-bezos">changing the world.</a>
Capitalism for Good: Draper is best known for his focus on Bitcoin these days. The venture capitalist said he wants to be useful and help drive Bitcoin forward, something that keeps him motivated to keep working.
During a recent appearance on "<a href="https://www.benzinga.com/razreport">The Raz Report</a>" podcast with Benzinga founder Jason Raznick, Draper said he hopes Bitcoin makes it so that billions of people who aren't part of the world economy can participate.
Draper explained that Amazon founder Jeff Bezos is super rich thanks to Amazon, but he also has made many people's lives better with the company he created.
"Amazon has made all of our lives so much better," Draper said.
Draper said he has benefitted from what Bezos has done and that's a part of the world economy that isn't spoken about enough.
"Those geniuses who create this incredible world for us are benefitting all of us."
Draper said this is part of capitalism where the inventors benefit but the consumers also win.
"We're better off because of it,&#8221; he said, adding, "I benefit hugely from what Jeff Bezos has done.&#8221;
Read Also: <a href="https://www.benzinga.com/25/03/44313499/elon-musk-is-a-gift-from-the-gods-why-a-venture-capitalist-thinks-billionaire-will-help-america-look-really-cool">Elon Musk Is &#8216;A Gift From The Gods&#8217;: Why A Venture Capitalist Thinks Tesla CEO Will Help America Look &#8216;Really Cool&#8217;</a>
Why It's Important: Draper used the reference to Bezos to compare to Bitcoin. The venture capitalist said this is the same with Bitcoin as he hopes that he can be a figure that helps the world economy with the leading cryptocurrency.
This is what drives Draper and keeps him working rather than sitting on a beach retired.
Draper said he funded Hotmail, which helped people send free emails around the world. He funded Skype which gave people the ability to use video to connect. His funding of Tesla helped consumers have electric vehicles and not have to settle for traditional gas vehicles.
While Draper made money on all these investments, he said it's important to see capitalism at work.
"The beneficiary is not just the one who made money. The beneficiary is the consumer."
Watch the full interview with Tim Draper below. 
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Tim Draper's Boldest Bitcoin Prediction Yet" width="500" height="281" src="https://www.youtube.com/embed/vZgN6kewPU0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Photo: Shutterstock

Entertainment

Exclusives

Interview

AMZN

Jeff Bezos Is Genius Who Helped Benefit Himself And The World With Amazon, VC Says: 'The Beneficiary Is The Consumer'

GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) has outperformed the market over the past 5 years by 23.54% on an annualized basis producing an average annual return of 40.42%. Currently, GE Aerospace has a market capitalization of $207.22 billion. 
Buying $1000 In GE: If an investor had bought $1000 of GE stock 5 years ago, it would be worth $5,803.02 today based on a price of $193.00 for GE at the time of writing.
<h3>GE Aerospace's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741904116_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In GE Aerospace 5 Years Ago Would Be Worth This Much Today

Guidance

OPAL

OPAL Fuels Expects FY25 Adjusted EBITDA Of $90M - $110M

Global asset management firm Krane Funds Advisors introduced its Single-Stock Levered ETF Suite with the launch of the KraneShares 2X Long PDD Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPDD#NASDAQ">KPDD</a>) and the KraneShares 2X Long BABA Daily ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBAB#NASDAQ">KBAB</a>) that began trading Thursday on Nasdaq.
KPDD and KBAB are structured to provide 200% of the daily percentage change of their respective underlying stocks, prior to fees and expenses. This gives investors with<a href="https://www.benzinga.com/etfs"> leveraged exposure </a>to PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) and Alibaba (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>).
KPDD comes with an expense ratio of 1.26%, and KBAB has a management charge of 0.99%. Nonetheless, KraneShares has imposed a fee waiver for KBAB until Aug. 1, 2026.
Also Read:<a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/03/44301370/smart-etf-picks-for-a-cooling-inflation-era"> Smart ETF Picks For A Cooling Inflation Era</a>
PDD Holdings is a&nbsp;world-leading&nbsp;e-commerce&nbsp;player&nbsp;with&nbsp;presence&nbsp;in&nbsp;more&nbsp;than&nbsp;19 countries. Its&nbsp;overseas&nbsp;platform, Temu,&nbsp;outpaced&nbsp;Amazon&#8217;s&nbsp;monthly active&nbsp;buyers&nbsp;and&nbsp;reached&nbsp;$50 billion&nbsp;annual gross merchandise&nbsp;volume&nbsp;in 2024.
Meanwhile, Alibaba, the world&#8217;s third-largest e-commerce retailer, has increased its footprint in AI, cloud computing, logistics, fintech, and media. Its shares have recently picked up pace after it introduced its Qwen2.5 series large language model and a new AI collaboration with Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) to include cutting-edge features on iPhones being sold in China.
Both PDD and Alibaba have&nbsp;been&nbsp;among the&nbsp;most&nbsp;prominent&nbsp;holdings&nbsp;within&nbsp;the KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>). 
Leveraged ETFs like KPDD and KBAB provide an efficient way for investors to amplify their exposure to leading Chinese internet stocks. "China Internet continues to be an important global growth theme," <a href="https://kraneshares.com/kraneshares-launches-single-stock-levered-etf-suite-with-2x-investment-exposure-to-temu-parent-pdd-holdings-kpdd-and-alibaba-kbab/">said </a>James Maund, KraneShares' Head of Capital Markets. "Our Single-Stock Levered ETF Suite provides a convenient way for bullish investors to gain levered exposure to top companies, including the largest China internet stocks."
These funds do,&nbsp;however,&nbsp;contain&nbsp;a&nbsp;lot&nbsp;of&nbsp;risk. They are&nbsp;meant&nbsp;for&nbsp;single-day trading,&nbsp;so&nbsp;their&nbsp;performance&nbsp;is&nbsp;best&nbsp;used&nbsp;for short-term&nbsp;purposes.&nbsp;Keeping&nbsp;them&nbsp;for&nbsp;more&nbsp;than&nbsp;a day can&nbsp;result&nbsp;in&nbsp;returns&nbsp;compounding in a way&nbsp;that&nbsp;could&nbsp;stray&nbsp;from twice the&nbsp;performance of the&nbsp;stock&nbsp;due to market&nbsp;conditions.
Mechanics of KPDD and KBAB
The KBAB&nbsp;seeks&nbsp;to&nbsp;replicate&nbsp;200% of&nbsp;Alibaba&#8217;s ADR,&nbsp;on&nbsp;a&nbsp;daily basis.&nbsp;This&nbsp;is&nbsp;accomplished&nbsp;through an investment&nbsp;in Alibaba&nbsp;stock and&nbsp;the&nbsp;use of&nbsp;swap agreements and options to&nbsp;multiply&nbsp;returns.
In the same way, the KPDD&nbsp;aims&nbsp;to&nbsp;double the daily returns of PDD Holdings&#8217;&nbsp;ADR.&nbsp;Similar&nbsp;to&nbsp;KBAB, it&nbsp;uses&nbsp;swaps and options for leveraged exposure and&nbsp;daily&nbsp;rebalancing.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/03/44290482/steel-aluminum-import-tariff-threat-4-etfs-gaining-losing-in-the-market-shake-up">Steel &amp; Aluminum Import Tariff Threat: 4 ETFs Gaining &amp; Losing In The Market Shake-Up</a></li>
</ul>
Image via Shutterstock

New ETFs

ETFs

AAPL

BABA

KBAB

KPDD

KWEB

Citigourp Global Markets 2% Protected Notes Linked To The Djia

KraneShares Launches Single-Stock Leveraged ETF Suite Featuring Alibaba And PDD Holdings

OPAL Fuels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPAL#NASDAQ">OPAL</a>) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.19 by 126.32 percent. This is a 145.45 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $80.02 million which missed the analyst consensus estimate of $91.24 million by 12.30 percent. This is a 8.03 percent decrease over sales of $87.01 million the same period last year.

Earnings Misses

OPAL Fuels Q4 2024 GAAP EPS $(0.05) Misses $0.19 Estimate, Sales $80.02M Miss $91.24M Estimate

During the last three months, 11 analysts shared their evaluations of Molson Coors Beverage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $61.91, along with a high estimate of $72.00 and a low estimate of $48.00. This upward trend is apparent, with the current average reflecting a 3.96% increase from the previous average price target of $59.55.
<img src="https://www.benzinga.com/files/images/story/2025/1741903329_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Molson Coors Beverage among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$62.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$56.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$63.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Gerald Pascarelli</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$72.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Dara Mohsenian</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$63.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Gerald Pascarelli</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$72.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Gerald Pascarelli</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$72.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$57.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$58.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$48.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$58.00</td>
<td>$60.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Molson Coors Beverage. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Molson Coors Beverage compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Molson Coors Beverage's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Molson Coors Beverage's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/TAP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Molson Coors Beverage analyst ratings.</a>
<h2>Discovering Molson Coors Beverage: A Closer Look</h2>
Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the us, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the us, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.
<h3>Molson Coors Beverage: Financial Performance Dissected</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: Molson Coors Beverage's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -1.98%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Molson Coors Beverage's net margin excels beyond industry benchmarks, reaching 10.52%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Molson Coors Beverage's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.18%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Molson Coors Beverage's ROA excels beyond industry benchmarks, reaching 1.09%. This signifies efficient management of assets and strong financial health.
Debt Management: Molson Coors Beverage's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.47.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Demystifying Molson Coors Beverage: Insights From 11 Analyst Reviews

In the preceding three months, 10 analysts have released ratings for ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>), presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $131.5, a high estimate of $157.00, and a low estimate of $114.00. Highlighting a 4.71% decrease, the current average has fallen from the previous average price target of $138.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1741903322_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of ConocoPhillips among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$115.00</td>
<td>$127.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$137.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$124.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$128.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$157.00</td>
<td>$148.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$132.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$139.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Ryan Todd</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$114.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$134.00</td>
<td>$132.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ConocoPhillips. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of ConocoPhillips compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for ConocoPhillips's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of ConocoPhillips's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/COP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on ConocoPhillips analyst ratings.</a>
<h2>Delving into ConocoPhillips's Background</h2>
ConocoPhillips is a US-based independent exploration and production firm. In 2023, it produced 1.2 million barrels per day of oil and natural gas liquids and 3.1 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2023 were 6.8 billion barrels of oil equivalent.
<h3>ConocoPhillips: Delving into Financials</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: ConocoPhillips's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -3.35%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Energy sector.
Net Margin: ConocoPhillips's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 16.01%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): ConocoPhillips's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 3.97%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.08%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.38, ConocoPhillips adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ConocoPhillips Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)

Analysts' ratings for Ovintiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OVV#NYSE">OVV</a>) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $53.33, a high estimate of $60.00, and a low estimate of $42.00. Experiencing a 5.33% decline, the current average is now lower than the previous average price target of $56.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1741903306_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Ovintiv among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$45.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$59.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$60.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>Noah Hungness</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$54.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$42.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$60.00</td>
<td>$63.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Ovintiv. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Ovintiv compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Ovintiv's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Ovintiv's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/OVV/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Ovintiv analyst ratings.</a>
<h2>Unveiling the Story Behind Ovintiv</h2>
Ovintiv Inc is a North American oil and natural gas exploration and production company that is focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs and natural gas. The company has two operating segments: USA Operations, and Canadian Operations. The USA Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within the United States. The Canadian Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within Canada.
<h3>A Deep Dive into Ovintiv's Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Challenges: Ovintiv's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -30.89%. This indicates a decrease in top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Ovintiv's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -2.74%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Ovintiv's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.57%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Ovintiv's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.31%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Ovintiv's debt-to-equity ratio is below the industry average. With a ratio of 0.61, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Ovintiv Stands With Analysts

Management

Press Releases

Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board

Health Care

General

Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases

Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success

Markets

Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program

Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate's (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models

Comments

Eterna Therapeutics

ニュース

最新ニュース Eterna Therapeutics (NASDAQ:ERNA) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル